JPRN-UMIN000029768尚未招募未知
A pilot study to establish simultaneous acquisition of 99m-Tc and 123-I-BMIPP tracers using SPECT with CZT detectors - A pilot study to establish simultaneous acquisition of 99m-Tc and 123-I-BMIPP tracers using SPECT with CZT detectors
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Unbearable to 15-minutes rest Potential pregnancy Previous enrollment within 28 days
研究者
相似试验
已完成
不适用
Beijing Adolescent Obesity Peer EducatioPublic Health - Health promotion/educationDiet and Nutrition - ObesityObesityACTRN12612000417886The George Institute for Global Health, China640
已完成
不适用
Exploring the feasibility and efficacy of intensive online Cognitive Behavioural Therapy for panic and anxiety: A pilot studyAgoraphobiaMental Health - AnxietyPanic DisorderACTRN12618001501235niversity of New South Wales10
进行中（未招募）
不适用
A pilot study investigating the effects of a combination of local and systemic anti-inflammatory adjuncts in patients undergoing vitrectomy and silicone oil for established Proliferative Vitreoretinopathy. - Anti-inflammatories in patients with PVRProliferative Vitreoretinopathy This is a scarring process that occurs in patients who have developed a retinal detachment. It is the primary cause of failure in retinal detachment surgery and occurs in 5-10% cases.EUCTR2004-001991-37-GBMoorfields Eye Hospital30
已完成
不适用
Self management and support programme (EDGE) for COPDChronic obstructive pulmonary disease.RespiratoryChronic obstructive pulmonary disease, unspecifiedISRCTN40367841Oxford University (UK)295
进行中（未招募）
不适用
Pilot phase 2 clinical trial performed in some hospitals to evaluate the efficacy and the adverse events in a group of patients with active bullous pemphigoid that will receive DF2156A at the dose of 150 mg, oral route, twice a day.active bullous pemphigoidMedDRA version: 14.0Level: LLTClassification code 10006567Term: Bullous pemphigoidSystem Organ Class: 10040785 - Skin and subcutaneous tissue disordersEUCTR2011-000756-42-DEDompé s.p.a.12